Investing.com - Financial Markets Worldwide

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF (1621)

Tokyo
Currency in JPY
25,085.0
+305.0(+1.23%)
Closed·
Day's Range
24,925.025,090.0
52 wk Range
23,335.031,870.0
Bid/Ask
25,065.00 / 25,085.00
Prev. Close
24,780
Price Open
24,985.00
Volume
1,204
Average Volume (3m)
736
1-Year Change
-11.42%
Day's Range
24,925-25,090
52 wk Range
23,335-31,870
Market Cap
4.17B
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
Explore
Type:ETF
Market:Japan
Issuer:Nomura Asset Management Co Ltd
Underlying:Tokyo SE TOPIX17 Pharmacetical Stock Price
ISIN:JP3046600007
Asset Class:Equity
How do you feel today about 1621?
Vote to see community's results!
or

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 10009649819611,1771,2481,583
Fund Return-3.64%-1.92%-3.92%+5.59%+4.54%+4.7%

Holdings

Upside

Takeda Pharmaceutical Co., Ltd.

450223.40%
aa.aa
4,078.0+0.49%238,200

Daiichi Sankyo Co., Ltd.

456820.50%
aa.aa
3,454.0+2.77%247,600

Chugai Pharmaceutical Co., Ltd.

451915.99%
aa.aa
7,527.0+0.16%83,800

Otsuka Holdings Ltd

457810.98%
aa.aa
6,612.0+1.01%66,100

Astellas Pharma Inc.

45037.59%
aa.aa
1,366.0+1.86%234,800

Shionogi & Co., Ltd.

45074.82%
aa.aa
2,220.0+1.44%88,800

Eisai Co., Ltd.

45233.22%
aa.aa
3,731.0+1.75%34,900

Ono Pharmaceutical Ltd

45281.97%
aa.aa
1,516.5+1.64%54,800

Santen Pharmaceutical Co Ltd

45361.60%
aa.aa
1,569.5+4.25%47,800

Kyowa Kirin Co Ltd

41511.58%
aa.aa
2,211.0+1.77%31,500

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF Company Profile

NEXT FUNDS TOPIX-17 Pharmaceutical ETF is an exchange traded fund launched and managed by Nomura Asset Management Co., Ltd. The fund invests in the public equity markets of Japan. It seeks to invest in the stocks of companies operating in the pharmaceutical sector. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the TOPIX-17 PHARMACEUTICAL Index, by investing in the stocks of companies as per their weightings in the index. NEXT FUNDS TOPIX-17 Pharmaceutical ETF was formed on March 21, 2008 and is domiciled in Japan.

Industry
-
Sector
-
0
Equity Type
ETF
Market
Japan

FAQ

How is the performance of 1621?

As of 17 May 2025, 1621 is trading at a price of 25,085.00, with a previous close of 24,780.00. The stock has fluctuated within a day range of 24,925.00 to 25,090.00, while its 52-week range spans from 23,335.00 to 31,870.00.

What is the current price of 1621?

The 1621 stock price today is 25,085.00.

Does 1621 Pay Dividends? What’s The Current Dividend Yield?

The NEXT FUNDS TOPIX-17 Pharmaceutical dividend yield is 2.15%.

What is the P/E ratio of 1621?

The P/E ratio for 1621 is 19.77.

From a Technical Analysis Perspective, Is 1621 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What is the 1621 market cap?

The market cap for 1621 is 4.17B.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.